125 related articles for article (PubMed ID: 7745984)
21. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
22. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
Tähtelä R; Thölix E
Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
[TBL] [Abstract][Full Text] [Related]
23. Systemic glucocorticoid treatment decreases serum concentrations of carboxyterminal propeptide of type I procollagen and aminoterminal propeptide of type III procollagen.
Oikarinen A; Autio P; Vuori J; Väänänen K; Risteli L; Kiistala U; Risteli J
Br J Dermatol; 1992 Feb; 126(2):172-8. PubMed ID: 1536783
[TBL] [Abstract][Full Text] [Related]
24. Insulin-like growth factor-I raises serum procollagen levels in children and adults with Laron syndrome.
Klinger B; Jensen LT; Silbergeld A; Laron Z
Clin Endocrinol (Oxf); 1996 Oct; 45(4):423-9. PubMed ID: 8959080
[TBL] [Abstract][Full Text] [Related]
25. Serum procollagen type 1 amino-terminal propeptide (P1NP) as an early predictor of the growth response to growth hormone treatment: Comparison of intrauterine growth retardation and idiopathic short stature.
Gascoin-Lachambre G; Trivin C; Brauner R; Souberbielle JC
Growth Horm IGF Res; 2007 Jun; 17(3):194-200. PubMed ID: 17321775
[TBL] [Abstract][Full Text] [Related]
26. Plasma concentrations of the carboxyterminal propeptide of type I procollagen (PICP) in preterm neonates from birth to term.
Seibold-Weiger K; Wollmann HA; Ranke MB; Speer CP
Pediatr Res; 2000 Jul; 48(1):104-8. PubMed ID: 10879807
[TBL] [Abstract][Full Text] [Related]
27. Collagen metabolites in the prediction of response to GH therapy in short children.
Tapanainen P; Knip M; Risteli L; Kemppainen L; Käär ML; Risteli J
Eur J Endocrinol; 1997 Dec; 137(6):621-5. PubMed ID: 9437226
[TBL] [Abstract][Full Text] [Related]
28. Serum levels of bone Gla protein (osteocalcin, BGP) and carboxyterminal propeptide of type I procollagen (PICP) in acromegaly: effects of long-term octreotide treatment.
Terzolo M; Piovesan A; Osella G; Pia A; Reimondo G; Pozzi C; Raucci C; Torta M; Paccotti P; Angeli A
Calcif Tissue Int; 1993 Mar; 52(3):188-91. PubMed ID: 8481830
[TBL] [Abstract][Full Text] [Related]
29. Long-term monitoring of treatment with recombinant human growth hormone by serial determinations of type III procollagen-related antigens in serum.
Danne T; Grüters A; Schnabel K; Burger W; L'Allemand D; Enders I; Helge H; Weber B
Pediatr Res; 1988 Feb; 23(2):167-71. PubMed ID: 3353159
[TBL] [Abstract][Full Text] [Related]
30. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
[TBL] [Abstract][Full Text] [Related]
31. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
Bolarin M
J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
[TBL] [Abstract][Full Text] [Related]
32. Type III and type I procollagen markers in fibrosing alveolitis.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
[TBL] [Abstract][Full Text] [Related]
33. Long-term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency.
Sartorio A; Arosio M; Conti A; Ferrero S; Porretti S; Faglia G
J Endocrinol Invest; 1999 Mar; 22(3):169-75. PubMed ID: 10219883
[TBL] [Abstract][Full Text] [Related]
34. Growth velocity, growth hormone therapy, and serum concentrations of the amino-terminal propeptide of type III procollagen.
Trivedi P; Hindmarsh P; Risteli J; Risteli L; Mowat AP; Brook CG
J Pediatr; 1989 Feb; 114(2):225-30. PubMed ID: 2915282
[TBL] [Abstract][Full Text] [Related]
35. External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph.
Jensen LT; Olesen HP; Risteli J; Lorenzen I
Lab Anim Sci; 1990 Nov; 40(6):620-4. PubMed ID: 2172627
[TBL] [Abstract][Full Text] [Related]
36. [Normal levels of carboxyterminal propeptide of type I procollagen in the first three months of life].
Praticò G; Caltabiano L; Palano GM; Sciacca P; D'Agata A
Pediatr Med Chir; 1995; 17(2):127-9. PubMed ID: 7610074
[TBL] [Abstract][Full Text] [Related]
37. [Procollagen III propeptide. Values in the course of pediatric celiac disease].
Hauptmann C; Johannsen B
Monatsschr Kinderheilkd; 1992 Dec; 140(12):857-63. PubMed ID: 1491706
[TBL] [Abstract][Full Text] [Related]
38. Serum procollagen I carboxyterminal propeptide (PICP) levels through puberty: relation to height velocity and serum hormone levels.
Rotteveel J; Schoute E; Delemarre-van de Waal HA
Acta Paediatr; 1997 Feb; 86(2):143-7. PubMed ID: 9055882
[TBL] [Abstract][Full Text] [Related]
39. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
40. The carboxyterminal propeptide of procollagen type I (PICP) in serum and biological fluids.
Risteli L
Scand J Clin Lab Invest Suppl; 1990; 202():143-6. PubMed ID: 2075430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
